FDA labeling

Wegovy and Zepbound are labeled for adults with BMI ≥30, or ≥27 with at least one weight-related comorbidity.

Off-label and compounded use

Some providers prescribe compounded GLP-1 below those thresholds based on a prescriber’s clinical judgment. The legal latitude is real but not infinite.

Be honest on your intake

Misrepresenting BMI on a telehealth intake form is fraud and gets your script revoked.